• Gut Dysbiosis, NF-κB–IL6–STAT3, and Docetaxel Resistance

  2026-10-02

  Zhong et al. link antibiotic-associated gut dysbiosis to prostate cancer progression and Docetaxel resistance through increased permeability, intratumoral lipopolysaccharide, and NF-κB–IL6–STAT3 signaling. The study combines mouse tumor models, fecal microbiota transplantation, 16S rRNA profiling, mechanistic assays, and patient samples to connect microbiome composition with treatment-relevant disease behavior.

• Carbapenemase Gene Transmission in CREC, 2022–2024

  2026-10-01

  This study integrates gene localization, plasmid conjugation, mobile genetic element profiling, and strain typing to examine carbapenemase dissemination in carbapenem-resistant Enterobacter cloacae across eight Guangdong teaching hospitals. Its findings identify dominant blaNDM-1 carriage, frequent transferability, and multidrug resistance as interconnected priorities for antimicrobial resistance research and hospital infection-control modeling.

• Cefiderocol Activity in Resistant European Non-Fermenters

  2026-10-01

  This European surveillance study directly compared cefiderocol with newer β-lactam/β-lactamase inhibitor combinations against Pseudomonas aeruginosa and Acinetobacter spp., including meropenem-resistant isolates. Cefiderocol retained high in vitro susceptibility across resistant subsets, while genomic findings implicated iron-uptake pathway changes in many cefiderocol-resistant isolates and support parallel susceptibility testing rather than assumptions based on cross-resistance.

• Idoxuridine Workflows for Viral DNA Research

  2026-09-30

  Idoxuridine provides a mechanistically grounded way to interrogate viral DNA synthesis, but reliable results depend on stock handling, matched vehicle controls, and orthogonal genome, infectivity, and cell-health readouts. This workflow also adapts a rapid, reversible perturbation strategy from human neuron research without implying that the pain study validates antiviral activity.

• Cefoperazone Sodium Salt for Resistance Assays

  2026-09-30

  Cefoperazone sodium salt supports reproducible MIC, MBC, β-lactamase stability, and biliary tract infection research workflows. This guide translates comparative antimicrobial evidence into practical assay design, formulation controls, and troubleshooting decisions for gram-negative bacterial resistance studies.

• 5-(N,N-dimethyl)-Amiloride in Endothelial Assays

  2026-09-29

  Use 5-(N,N-dimethyl)-Amiloride hydrochloride to separate Na+/H+ exchanger-dependent pH and sodium flux from downstream endothelial barrier injury. This workflow pairs DMA with moesin, permeability, and signaling readouts for more informative sepsis and cardiovascular research.

• Mouse Neutrophil Cell Isolation Kit for Tumor Assays

  2026-09-29

  Build cleaner neutrophil assays for tumor immunology, cytokine response studies, and mRNA nanovaccine validation. Negative selection removes labeled unwanted cells while leaving target neutrophils untouched, supporting high-purity, function-focused experiments.

• From CRISPR Hits to Host-State Biology in Brucella

  2026-09-28

  A translational framework for moving from host-gene discovery in Brucella infection to experimentally controlled macrophage-state perturbation with SDF-1beta (CXCL12), human recombinant.

• Nitrocefin Assays for β-Lactamase Research

  2026-09-28

  Nitrocefin turns β-lactamase activity into a rapid yellow-to-red signal, making it useful for enzyme characterization and first-pass inhibitor screening. This guide shows how to build a controlled assay, interpret results cautiously, and apply the readout to emerging resistance research such as GOB-38 in Elizabethkingia anophelis.

• Aztreonam Workflows for Gram-Negative Research

  2026-09-27

  Build reproducible Gram-negative research assays with Aztreonam, a monocyclic β-lactam antibiotic suited to studying bacterial cell-wall inhibition and resistance phenotypes. Practical guidance covers solution preparation, exploratory susceptibility workflows, assay controls, and the limits of translating preclinical findings across experimental systems.

• BML-277 and the CHK2–cGAS Genome-Integrity Axis

  2026-09-26

  Explore how BML-277, a potent Chk2 inhibitor, can help researchers test the connection between DNA damage signaling and nuclear cGAS control of LINE-1 activity. This article translates a recent mechanistic discovery into cautious, testable assay strategies while distinguishing established findings from hypotheses.

• Ceftolozane Sulfate: Assay Design for Resistance Biology

  2026-09-25

  Ceftolozane sulfate research is most informative when susceptibility results are interpreted alongside resistance mechanisms and drug exposure. This guide connects target biology, assay design, and translational models while distinguishing ceftolozane activity from that of the ceftolozane–tazobactam combination.

• Imipenem Workflows for Antibacterial Research

  2026-09-25

  Imipenem supports more than susceptibility testing: its PBP-directed antibacterial activity and reported effects on phagocytosis make it useful for paired pathogen–host assays. This workflow guide connects bench screening to emerging localized-delivery research while distinguishing established findings from exploratory applications.

• MTT Assay: Workflow, Applications & Troubleshooting

  2026-09-24

  Use MTT to compare metabolic activity across treatment groups, including bone marrow stromal cell studies, while keeping in mind that signal is not a direct cell count. This practical guide covers an adaptable workflow, controls, optimization, and the interpretation lessons from research on neohesperidin and steroid-induced osteonecrosis.

• VX-765 and the Logic of Cell-Death Assays

  2026-09-24

  VX-765 helps researchers test whether inflammatory cytokine release and macrophage pyroptosis depend on caspase-1. This article connects that focused use to new evidence that RNA polymerase II loss can trigger a distinct apoptotic response, offering a practical framework for interpreting cell-death assays without conflating mechanisms.

8017 records 3/535 page Previous Next 12345 下5页 Last page